Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease

International Journal of Cardiology

Volumn 189, Issue 1, 2015, Pages 182-184

  Carmo, Andre A L ^a   Rocha, Manoel O C ^a   Silva, Jose L P ^a   Ianni, Barbara M ^b   Fernandes, Fabio ^b   Sabino, Ester C ^b   Ribeiro, Antonio L P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amiodarone; Chagas disease; Parasitemia

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMIODARONE; DNA; ANTIARRHYTHMIC AGENT;

ADULT; CHAGAS DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LETTER; MALE; MIDDLE AGED; PARASITE LOAD; PARASITEMIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; QUANTITATIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; ISOLATION AND PURIFICATION; PARASITOLOGY; PATHOLOGY; TRYPANOSOMA CRUZI; VENTRICULAR FIBRILLATION;

ADULT; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CHAGAS DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARASITE LOAD; PARASITEMIA; RETROSPECTIVE STUDIES; TRYPANOSOMA CRUZI; VENTRICULAR FIBRILLATION;

EID: 84929148677     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.04.061     Document Type: Article

References (10)

1. A.L. Ribeiro, M.P. Nunes, M.M. Teixeira, M.O. Rocha, Diagnosis and management of Chagas disease and cardiomyopathy, Nat. Rev. Cardiol. 9 (10) (2012) 576-589.
2. G. Benaim, A.E. Paniz Mondolfi, The emerging role of amiodarone and dronedarone in Chagas disease, Nat. Rev. Cardiol. 9 (10) (2012) 605-609.
3. G. Benaim, J.M. Sanders, Y. Garcia-Marchán, C. Colina, R. Lira, A.R. Caldera, et al., Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole, J. Med. Chem. 49 (3) (2006) 892-899.
4. A.E. Paniz-Mondolfi, A.M. Pérez-Alvarez, G. Lanza, E. Márquez, J.L. Concepción, Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease, Chemotherapy 55 (4) (2009) 228-233.
5. E.C. Sabino, T.H. Lee, L. Montalvo, M.L. Nguyen, D.A. Leiby, D.M. Carrick, et al, Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time, Transfusion 53 (6) (2013) 1257-1265.
6. S. Kleinman, M.R. King, M.P. Busch, E.L. Murphy, S.A. Glynn, NHLBIRED Study, et al, The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability, Transfus. Med. Rev. 26 (4) (2012) 281-304 (e1-2).
7. E.C. Sabino, A.L. Ribeiro, V.M. Salemi, C. Di Lorenzo Oliveira, A.P. Antunes, M.M. Menezes, et al., Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors, Circulation 127 (10) (2013) 1105-1115.
8. A.L. Ribeiro, E.C. Sabino, M.S. Marcolino, V.M. Salemi, B.M. Ianni, F. Fernandes, et al, Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors, PLoS Negl. Trop. Dis. 7 (2) (2013) e2078.
9. E.C. Sabino, A.L. Ribeiro, T.H. Lee, C.L. Oliveira, A.B. Carneiro-Proietti, A.P. Antunes, et al, Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity, Eur. J. Heart Fail. (2015 Feb 10) Epub.
10. J.S. Sekhon, R.D. Grieve, A matching method for improving covariate balance in cost-effectiveness analyses, Health Econ. 21 (6) (2012) 695-714.